Riskpilot← Back to searchSign inGet full accessMicrobe Biosolutions Aps
APSActiveCVR 43196782Oddesundvej 24All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20223 employees
Revenue 2024
DKK 1,6M
+39% vs 2023
EBITDA margin
26.5%
+188% vs 2023
Equity ratio
9.0%
Financial strength
Net profit 2024
DKK 20K
-73% vs 2023
| Revenue | DKK 1,6M | +39% |
| EBITDA | DKK 428K | +188% |
| Net profit | DKK 20K | -73% |
| Total assets | DKK 5M | +90% |
| Equity | DKK 447K | +5% |
| Employees | 3 | — |
Legal name
Microbe Biosolutions Aps
CVR number
43196782
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
13. april 2022
Share capital
DKK 400.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med fremstilling, salg og montering af hybride filtre, samt hermed beslægtet virksomhed efter bestyrelsens skøn.
Address
Oddesundvej 24
Phone
+4586571700
Email
sanne@danskplast.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 448 | 1.159 | 1.613 |
| Staff expenses | -488 | -1.010 | -1.185 |
| EBITDA | -40 | 149 | 428 |
| Depreciation & amort. | -16 | -16 | -296 |
| EBIT | -56 | 133 | 132 |
| Net financials | -29 | -54 | -127 |
| Profit before tax | -85 | 78 | 5 |
| Tax | -38 | 5 | -15 |
| Net profit | -47 | 73 | 20 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 2.104 | 2.608 | 4.958 |
| Equity | 353 | 427 | 447 |
| Long-term debt | 0 | 506 | 573 |
| Short-term debt | 1.751 | 1.675 | 3.938 |
| Total debt | 1.751 | 2.181 | 4.511 |
EBITDA margin
26.5%
This company
15.8%
Market median
+68% vs market
20222024
Equity ratio
9.0%
This company
38.2%
Market median
-76% vs market
20222024
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20222024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20222024
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20222024
Debt / equity
10.10×
This company
0.62×
Market median
-1529% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-04-13 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JS Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
LA Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KWS HOLDING, TJÆREBORG ApS | Company | 50.0% | 50.0% | 2022 |
Buddy Invest Aps | Company | 25.0% | 25.0% | 2025 |
LOBI HOLDING ApS | Company | 25.0% | 25.0% | 2025 |
Arreskov Holding ApS | Company | 5.0% | 5.0% | 2022 |
BECH ANDERSEN CONSULTING ApS | Company | 20.0% | 20.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LOBI HOLDING ApS
Microbe Biosolutions Aps Board members of Microbe Biosolutions Aps also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Sparrevohn | Chief Executive Officer | 0 companies |
| Lars Arreskov Mørch | Management | 0 companies |
| Steen Møbjerg Christensen | Chairman | 0 companies |
| Lars Ole Møller Jensen | Board of Directors | 0 companies |
| Klaus Westergaard Sørensen | Board of Directors | 0 companies |
| Birgitte Leisner Jensen | Board of Directors | 0 companies |
| Kristian Bech Andersen | Chairman | 0 companies |